Pimavanserin for impulse control issues in Parkinson's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests a medication called pimavanserin to see if it helps reduce impulse control problems (like compulsive gambling or eating) in people with Parkinson's disease. If you struggle with these behaviors, this treatment might bring relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have Parkinson's disease for at least one year.
- You need to have moderately severe impulse control issues like compulsive gambling, buying, eating, or hypersexuality.
- These behaviors must have started after you began taking Parkinson's medications.
- Your Parkinson's medications must be stable for at least one month before the study starts.
- You must not have serious heart conditions or recent heart problems.
- You must be between 35 and 75 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a computer-based tool that aims to predict and prevent impulse control disorders (like compulsive gambling or shopping) caused by certain Parkinson's medications. If you take a dopamine agonist, this tool might help your doctor adjust your treatment to avoid these side effects.
This trial tests whether a type of non-invasive brain stimulation called TMS can help reduce impulse control problems (like gambling or compulsive eating) that are caused by Parkinson's medications. It's for people with Parkinson's who are living with these side effects.
This trial tests whether deep brain stimulation (DBS) of the subthalamic nucleus can help control impulse control problems (like gambling, overeating, or shopping) in people with Parkinson's disease. It is for patients whose medication-related impulse symptoms are moderate to severe and who are good candidates for DBS surgery.
This study uses a special PET brain scan tracer to better understand serotonin receptor activity in people with certain neurodegenerative conditions, especially when they develop hallucinations or delusions. The results may help researchers improve how these brain changes are measured and tracked over time.
This study tests whether behavioral therapy (like bladder training and pelvic floor exercises) alone, or combined with a medication called mirabegron, is better at improving bladder symptoms (like sudden urges and frequent urination) in people with Parkinson's disease. The goal is to see which approach helps reduce urgency and improve daily life.
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.